Aquestive Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones12/20 20:52

Sector Update: Health Care Stocks Lower Thursday Afternoon

MT Newswires12/20 02:49

Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity For Libervant Buccal Film In Pediatric Patients With Seizure Clusters Ages 2-5

Benzinga12/19 21:09

Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside

Benzinga12/18 02:56

Aquestive Therapeutics Initiated at Overweight by Cantor Fitzgerald

Dow Jones12/17 22:03

Aquestive Therapeutics Analyst Ratings

Benzinga12/17 21:51